Recombinant anti-mouse PD-L1 / VEGF-A bispecific antibodies share the variable region sequences with the rat anti-mouse PD-L1 antibody (clone number: 10F.9G2) and the mouse anti-mouse VEGF antibody (clone number: B20-4.1.1). The recombinant mouse IgG2c LALAPG bispecific...
Recombinant anti-mouse PD-1 / VEGF bispecific antibodies share the variable region sequences with the rat anti-mouse PD-1 antibody (clone number: 29F.1A12) and the mouse anti-mouse VEGF antibody (clone number: B20-4.1.1). The recombinant mouse IgG2c LALAPG bispecific...
Recombinant anti-mouse PD-1 / VEGF bispecific antibodies share the variable region sequences with the rat anti-mouse PD-1 antibody (clone number: RMP1-14) and the mouse anti-mouse VEGF antibody (clone number: B20-4.1.1). The recombinant mouse IgG2c LALAPG bispecific...
Recombinant anti-mouse CD370 / PD L1 bispecific antibodies share the variable region sequences with the rat anti-mouse CD370 antibody (clone number: 10B4) and the rat anti-mouse PD-L1 antibody (clone number: 10F.9G2). The recombinant mouse IgG2c LALAPG...
Recombinant mouse IgG2b isotype control and mutants good for in vitro and in vivo studies. Low or no specific binding to mouse samples tested. More choices of recombinant mouse IgG2b isotype controls, including targets, mutants,...
Recombinant mouse IgG3 kappa isotype control for in vitro and in vivo studies. Low or no specific binding to mouse samples tested. More choices of recombinant mouse IgG3 isotype controls, including targets, mutants, tags, and conjagates.
Recombinant mouse IgG1 kappa isotype control and mIgG1 D265A isotype control mutant for in vitro and in vivo studies. Low or no specific binding to mouse samples tested. More choices of recombinant mouse IgG1 isotype...
Recombinant mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
